橙皮苷纳米颗粒对扑热息痛中毒小鼠CYP2E1和CYP3A11调控作用的优化

IF 2.2 4区 医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY
Mona M Mohamed, Mohammed A Hussein, Sahar M Elashmony, Eman R Saifeldeen, Tamer Roshdy, Azza M Metwaly
{"title":"橙皮苷纳米颗粒对扑热息痛中毒小鼠CYP2E1和CYP3A11调控作用的优化","authors":"Mona M Mohamed, Mohammed A Hussein, Sahar M Elashmony, Eman R Saifeldeen, Tamer Roshdy, Azza M Metwaly","doi":"10.2174/0113892010336010250212060619","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hesperidin is a flavonoid found in citrus fruits, particularly in the peel and pulp of oranges and lemons. By encapsulating drugs or bioactive compounds within NPs, it's possible to enhance their stability, solubility, and bioavailability. The current investigation aims to optimize hesperidin nanoparticles (Hes-NPs) and evaluate their hepatoprotective and antioxidant effects in paracetamol-intoxicated mice.</p><p><strong>Methods: </strong>The characteristics of Hes-NPs were elucidated, including morphology, particle size, zeta potential, UV-vis, entrapment efficiency, and FT-IR spectra. Hes-NPs were also tested for their hepatoprotective and antioxidant effects in paracetamol-treated mice. Safety and toxicity assessments are crucial before pharmacological studies. In addition, liver enzymes, oxidative stress, inflammatory biomarkers, and gene expression of CYP2E1 and CYP3A11 were measured. Furthermore, the study examined the molecular docking of hesperidin with the CYP2E1 and CYP3A11 proteins.</p><p><strong>Results: </strong>The synthesized Hes-NPs were uniform, spherically shaped, and well dispersed, with no aggregation noted, with a size range of 155.12 ± 14.13 nm. The measured zeta potential value of Hes-NPs was -21.57 ± 0.8 mV with a polydispersity index (PDI) of 0.49. Also, the UV spectra of hesperidin are at 220 and 279 nm, and Hes-NPs have strong absorption at 225 and 280 nm. Also, the LD50 of Hes-NPs was 1137.5 mg/kg b.w. Moreover, administering paracetamol-intoxicated mice with Hes-NPs resulted in improved plasma lipid profile &amp;#40;TC, TG, and HDL-C&amp;#41; and liver enzymes (ALT, AST, ALP, and LDH) as well as oxidative stress (GSH, SOD, CAT, Pr-SHs, and MDA) and inflammatory (TNF-α) biomarker levels, as well as attenuated CYP2E1, and CYP3A11 gene expression. In-silicon results proved that hesperidin showed a stronger estimated binding affinity with a ∆G of -8.6 and -10.5 kcal/mol. towards CYP2E1, and CYP3A11 activity, respectively. Our results showed that hesperidin forms hydrogen bonds with amino acid residues through the 9 and 12 bonds of CYP2E1 and CYP3A11, respectively.</p><p><strong>Conclusion: </strong>Hes-NPs could offer several advantages. It can be designed to specifically target liver cells, minimizing off-target effects, enhancing bioavailability, and shielding hesperidin from degradation in the body. The current results suggest that Hes-NPs may enhance antioxidant defenses and protect against oxidative stress in paracetamol-intoxicated mice.</p>","PeriodicalId":10881,"journal":{"name":"Current pharmaceutical biotechnology","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Optimization of Hesperidin Nanoparticles as a Promising CYP2E1 and CYP3A11 Regulator in Paracetamol-Intoxicated Mice.\",\"authors\":\"Mona M Mohamed, Mohammed A Hussein, Sahar M Elashmony, Eman R Saifeldeen, Tamer Roshdy, Azza M Metwaly\",\"doi\":\"10.2174/0113892010336010250212060619\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Hesperidin is a flavonoid found in citrus fruits, particularly in the peel and pulp of oranges and lemons. By encapsulating drugs or bioactive compounds within NPs, it's possible to enhance their stability, solubility, and bioavailability. The current investigation aims to optimize hesperidin nanoparticles (Hes-NPs) and evaluate their hepatoprotective and antioxidant effects in paracetamol-intoxicated mice.</p><p><strong>Methods: </strong>The characteristics of Hes-NPs were elucidated, including morphology, particle size, zeta potential, UV-vis, entrapment efficiency, and FT-IR spectra. Hes-NPs were also tested for their hepatoprotective and antioxidant effects in paracetamol-treated mice. Safety and toxicity assessments are crucial before pharmacological studies. In addition, liver enzymes, oxidative stress, inflammatory biomarkers, and gene expression of CYP2E1 and CYP3A11 were measured. Furthermore, the study examined the molecular docking of hesperidin with the CYP2E1 and CYP3A11 proteins.</p><p><strong>Results: </strong>The synthesized Hes-NPs were uniform, spherically shaped, and well dispersed, with no aggregation noted, with a size range of 155.12 ± 14.13 nm. The measured zeta potential value of Hes-NPs was -21.57 ± 0.8 mV with a polydispersity index (PDI) of 0.49. Also, the UV spectra of hesperidin are at 220 and 279 nm, and Hes-NPs have strong absorption at 225 and 280 nm. Also, the LD50 of Hes-NPs was 1137.5 mg/kg b.w. Moreover, administering paracetamol-intoxicated mice with Hes-NPs resulted in improved plasma lipid profile &amp;#40;TC, TG, and HDL-C&amp;#41; and liver enzymes (ALT, AST, ALP, and LDH) as well as oxidative stress (GSH, SOD, CAT, Pr-SHs, and MDA) and inflammatory (TNF-α) biomarker levels, as well as attenuated CYP2E1, and CYP3A11 gene expression. In-silicon results proved that hesperidin showed a stronger estimated binding affinity with a ∆G of -8.6 and -10.5 kcal/mol. towards CYP2E1, and CYP3A11 activity, respectively. Our results showed that hesperidin forms hydrogen bonds with amino acid residues through the 9 and 12 bonds of CYP2E1 and CYP3A11, respectively.</p><p><strong>Conclusion: </strong>Hes-NPs could offer several advantages. It can be designed to specifically target liver cells, minimizing off-target effects, enhancing bioavailability, and shielding hesperidin from degradation in the body. The current results suggest that Hes-NPs may enhance antioxidant defenses and protect against oxidative stress in paracetamol-intoxicated mice.</p>\",\"PeriodicalId\":10881,\"journal\":{\"name\":\"Current pharmaceutical biotechnology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-05-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current pharmaceutical biotechnology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2174/0113892010336010250212060619\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current pharmaceutical biotechnology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0113892010336010250212060619","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:橙皮苷是一种类黄酮,存在于柑橘类水果中,尤其是橘子和柠檬的果皮和果肉中。通过在NPs内包封药物或生物活性化合物,可以提高其稳定性,溶解度和生物利用度。本研究旨在优化橙皮苷纳米颗粒(Hes-NPs),并评估其对扑热息痛中毒小鼠的肝保护和抗氧化作用。方法:对Hes-NPs的形貌、粒径、zeta电位、UV-vis、包封效率、FT-IR光谱等进行表征。在对乙酰氨基酚处理的小鼠中也测试了Hes-NPs的肝保护和抗氧化作用。安全性和毒性评估在药理学研究之前至关重要。此外,检测肝酶、氧化应激、炎症生物标志物以及CYP2E1和CYP3A11的基因表达。此外,本研究还检测了橙皮苷与CYP2E1和CYP3A11蛋白的分子对接。结果:合成的Hes-NPs均匀,呈球形,分散良好,无聚集现象,粒径范围为155.12±14.13 nm。测得Hes-NPs的zeta电位值为-21.57±0.8 mV, PDI为0.49。橙皮苷在220和279 nm处有较强的紫外吸收,在225和280 nm处有较强的吸收。此外,Hes-NPs的LD50为1137.5 mg/kg b.w。此外,给予对乙酰氨基酚中毒小鼠Hes-NPs可改善血浆脂质水平[amp;#40];TC, TG和hdl - c [amp;#41];肝酶(ALT、AST、ALP和LDH)、氧化应激(GSH、SOD、CAT、Pr-SHs和MDA)和炎症(TNF-α)生物标志物水平,以及CYP2E1和CYP3A11基因表达减弱。In-silicon实验结果表明橙皮苷具有较强的结合亲和力,∆G为-8.6和-10.5 kcal/mol。分别影响CYP2E1和CYP3A11活性。我们的研究结果表明橙皮苷分别通过CYP2E1和CYP3A11的9和12键与氨基酸残基形成氢键。结论:Hes-NPs具有多种优势。它可以被设计成专门针对肝细胞,最大限度地减少脱靶效应,提高生物利用度,并屏蔽橙皮苷在体内降解。目前的研究结果表明,Hes-NPs可能增强对乙酰氨基酚中毒小鼠的抗氧化防御和抗氧化应激。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Optimization of Hesperidin Nanoparticles as a Promising CYP2E1 and CYP3A11 Regulator in Paracetamol-Intoxicated Mice.

Background: Hesperidin is a flavonoid found in citrus fruits, particularly in the peel and pulp of oranges and lemons. By encapsulating drugs or bioactive compounds within NPs, it's possible to enhance their stability, solubility, and bioavailability. The current investigation aims to optimize hesperidin nanoparticles (Hes-NPs) and evaluate their hepatoprotective and antioxidant effects in paracetamol-intoxicated mice.

Methods: The characteristics of Hes-NPs were elucidated, including morphology, particle size, zeta potential, UV-vis, entrapment efficiency, and FT-IR spectra. Hes-NPs were also tested for their hepatoprotective and antioxidant effects in paracetamol-treated mice. Safety and toxicity assessments are crucial before pharmacological studies. In addition, liver enzymes, oxidative stress, inflammatory biomarkers, and gene expression of CYP2E1 and CYP3A11 were measured. Furthermore, the study examined the molecular docking of hesperidin with the CYP2E1 and CYP3A11 proteins.

Results: The synthesized Hes-NPs were uniform, spherically shaped, and well dispersed, with no aggregation noted, with a size range of 155.12 ± 14.13 nm. The measured zeta potential value of Hes-NPs was -21.57 ± 0.8 mV with a polydispersity index (PDI) of 0.49. Also, the UV spectra of hesperidin are at 220 and 279 nm, and Hes-NPs have strong absorption at 225 and 280 nm. Also, the LD50 of Hes-NPs was 1137.5 mg/kg b.w. Moreover, administering paracetamol-intoxicated mice with Hes-NPs resulted in improved plasma lipid profile &#40;TC, TG, and HDL-C&#41; and liver enzymes (ALT, AST, ALP, and LDH) as well as oxidative stress (GSH, SOD, CAT, Pr-SHs, and MDA) and inflammatory (TNF-α) biomarker levels, as well as attenuated CYP2E1, and CYP3A11 gene expression. In-silicon results proved that hesperidin showed a stronger estimated binding affinity with a ∆G of -8.6 and -10.5 kcal/mol. towards CYP2E1, and CYP3A11 activity, respectively. Our results showed that hesperidin forms hydrogen bonds with amino acid residues through the 9 and 12 bonds of CYP2E1 and CYP3A11, respectively.

Conclusion: Hes-NPs could offer several advantages. It can be designed to specifically target liver cells, minimizing off-target effects, enhancing bioavailability, and shielding hesperidin from degradation in the body. The current results suggest that Hes-NPs may enhance antioxidant defenses and protect against oxidative stress in paracetamol-intoxicated mice.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Current pharmaceutical biotechnology
Current pharmaceutical biotechnology 医学-生化与分子生物学
CiteScore
5.60
自引率
3.60%
发文量
203
审稿时长
6 months
期刊介绍: Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences as they relate to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining food chemistry with pharmaceutical implication. Areas of interest include: DNA/protein engineering and processing Synthetic biotechnology Omics (genomics, proteomics, metabolomics and systems biology) Therapeutic biotechnology (gene therapy, peptide inhibitors, enzymes) Drug delivery and targeting Nanobiotechnology Molecular pharmaceutics and molecular pharmacology Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes) Pharmacokinetics and pharmacodynamics Applied Microbiology Bioinformatics (computational biopharmaceutics and modeling) Environmental biotechnology Regenerative medicine (stem cells, tissue engineering and biomaterials) Translational immunology (cell therapies, antibody engineering, xenotransplantation) Industrial bioprocesses for drug production and development Biosafety Biotech ethics Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信